
    
      Patients will take 150 mg of GSE product by mouth twice daily in the form of 75 mg capsule of
      Leucoselect Phytosome preparation; total oral dosage is 300 mg GSE per day for one year.
      Patients will be evaluated every 6 weeks for 3 months, then every 3 months thereafter for up
      to one year. PSA measurements will be obtained at these scheduled visits and patients must
      not have a doubling of their PSA (compared to baseline) by 3 months in order to continue on
      study. Patients who meet criteria to continue on study will be treated until disease
      progression or for one year (whichever comes first).
    
  